Is ProFunds UltraChina Investor (UGPIX) a Strong Mutual Fund Pick Right Now?

ProFunds UltraChina Investor (UGPIX) has delivered very weak performance, with a 5-year annualized total return of -29.28% and a 3-year annualized total return of -44.49%, placing it in the bottom third of its category. Risk is also high: standard deviation over 3 years is 83.26% vs a 1% category average and over 5 years is 71.76% vs 11%, along with negative 5-year alpha of -22.69 vs the S&P 500. Although it is relatively cheaper (1.85% expense ratio vs 37% category average), the article flags the fund as significantly more volatile and underperforming versus peers.

Analysis

This reads less like a standalone product review and more like another signal that China beta is still failing to earn its cost of capital for foreign allocators. The second-order effect is not the fund itself but the marginal flow problem: weak long-only performance keeps allocators underweight China, which reduces passive and active demand for HK-listed cyclicals, ADRs, and domestically exposed financials. That also reinforces fee compression for active China managers, which matters because fewer skilled capital providers means less cushion on drawdowns.

The market mechanism to watch is liquidity, not valuation. If China stimulus is broad enough to lift earnings revisions, capital can rotate quickly into FXI/MCHI/KWEB and related brokers, banks, and consumer names; if policy remains piecemeal, rallies will keep getting sold. Over the next 1-3 months, the key catalyst is whether credit impulse and property stabilization actually translate into higher household confidence and retail spending; over 6-18 months, persistent capital controls and state-heavy market intervention can keep the China risk premium structurally elevated.

Contrarian view: the crowd is already skeptical, so the direct bearish signal from one underperforming fund is limited. That argues against chasing a naked short in China beta unless macro data confirm renewed deterioration; otherwise, the better expression is relative value, not outright directional exposure. The clearest falsifier is a durable inflection in earnings revisions, PMI/new orders, or a stronger RMB that forces global managers to rebuild exposure quickly.

Key Decisions for Investors

• No immediate trade in YYYH; treat it as a sentiment/flow warning only. Reassess after the next round of China credit and earnings-revision data.
• Prefer a relative-value expression: long INDA or EWM versus short FXI for 1-3 months. Thesis is that marginal EM capital keeps rotating away from China toward higher-quality growth and better policy visibility.
• If China policy stimulus triggers a rally, use it to buy 2-4 month put spreads on FXI or KWEB rather than outright shorts. Best entry is on a policy-driven bounce that fails to broaden into earnings revisions.
• Watch for a reversal trigger: two consecutive months of improving credit impulse plus RMB strength. If that happens, cover China-beta shorts and rotate into HK/China internet proxies.
• Avoid shorting EEM outright here; China weakness can be offset by India, Taiwan, and commodity-linked EM. The cleaner trade is China-specific underweight versus broader EM.